您好,欢迎来到上海抚生实业有限公司!
400-990-7709 / 021-52961052(工作日9:00-18:00)
发布日期:2023/8/25 10:43:00

期刊:Oxidative Medicine and Cellular Longevity


文献题目:Anti-PD-L1 Antibody Enhances T Cell Immune Responses and Reduces Resistance of Breast Cancer Cells to Radiotherapy


作者:Guo Lei-Ming, Ding Gao-Feng, Xu Wen-Cai, Ge Hong, Jiang Yue, Lu Yu-Fei


DOI:10.1155/2022/5938688


引用产品: hematoxylin


影响因子:7.31


原文链接:https://www.hindawi.com/journals/omcl/2022/5938688

上一篇:JOURNAL OF CONTROLLED RELEASE 下一篇:Innovative Food Science & Emerging Technologies